Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.35 USD | +0.64% | +1.05% | -0.17% |
Feb. 23 | Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating | MT |
Feb. 22 | Transcript : Crescent Capital BDC, Inc., Q4 2023 Earnings Call, Feb 22, 2024 |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 410.4 | 495.7 | 394.7 | 644.1 | 643 | - |
Enterprise Value (EV) 1 | 410.4 | 495.7 | 394.7 | 644.1 | 643 | 643 |
P/E ratio | 7.36 x | 5.99 x | 25.6 x | 7.46 x | 7.86 x | 8.56 x |
Yield | 11.3% | 9.6% | 14% | 10.4% | 10.5% | 10.1% |
Capitalization / Revenue | 5.32 x | 5.27 x | 3.38 x | 3.5 x | 3.5 x | 3.72 x |
EV / Revenue | 5.32 x | 5.27 x | 3.38 x | 3.5 x | 3.5 x | 3.72 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | - | - | - | 0.87 x | - | 0.86 x |
Nbr of stocks (in thousands) | 28,167 | 28,167 | 30,887 | 37,062 | 37,062 | - |
Reference price 2 | 14.57 | 17.60 | 12.78 | 17.38 | 17.35 | 17.35 |
Announcement Date | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 53.48 | 77.11 | 93.99 | 116.7 | 184.1 | 183.7 | 173 |
EBITDA | - | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | - | - | - | 86.08 | 78.26 |
Net income 1 | 29.28 | 54.67 | 83.63 | 15.54 | 83.84 | 80.81 | 74.22 |
Net margin | 54.75% | 70.9% | 88.98% | 13.32% | 45.53% | 43.98% | 42.91% |
EPS 2 | - | 1.980 | 2.940 | 0.5000 | 2.330 | 2.208 | 2.028 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | 1.640 | 1.640 | 1.690 | 1.790 | 1.810 | 1.828 | 1.756 |
Announcement Date | 3/4/20 | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 25.48 | 24.14 | 26.38 | 26.77 | 28.99 | 34.58 | 39.28 | 46.74 | 48.15 | 49.96 | 47.7 | 46.76 | 45.2 | 44.09 | 44.17 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT | - | - | - | 15.35 | 15.5 | - | 30.06 | 20.79 | 21.96 | - | - | - | - | - | - |
Operating Margin | - | - | - | 57.33% | 53.46% | - | 76.53% | 44.48% | 45.6% | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 17.24 | 14.38 | 16.38 | 15.79 | 15.6 | 16.2 | 7.766 | 22.32 | 23.05 | 30.97 | 22.15 | 22.19 | 20.96 | 20.78 | 19.57 |
Net income 1 | 16.68 | 12.84 | 16.21 | -0.89 | -2.378 | 2.602 | 7.777 | 22.58 | 22.62 | 30.86 | 20.72 | 20.77 | 19.94 | 19.38 | 18.36 |
Net margin | 65.46% | 53.17% | 61.44% | -3.32% | -8.2% | 7.53% | 19.8% | 48.31% | 46.98% | 61.77% | 43.43% | 44.42% | 44.12% | 43.95% | 41.57% |
EPS 2 | 0.5900 | 0.4400 | 0.5200 | -0.0300 | -0.0800 | 0.0800 | 0.2400 | 0.6100 | 0.6100 | 0.8400 | 0.5767 | 0.5675 | 0.5350 | 0.5225 | 0.5133 |
Dividend per Share 2 | 0.4100 | 0.4600 | 0.4600 | 0.4600 | 0.4600 | 0.4100 | 0.4100 | 0.4100 | 0.4100 | 0.5000 | 0.4550 | 0.4500 | 0.4475 | 0.4425 | 0.4400 |
Announcement Date | 11/10/21 | 2/23/22 | 5/9/22 | 8/10/22 | 11/9/22 | 2/22/23 | 5/10/23 | 8/9/23 | 11/8/23 | 2/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | 8.79% | 10.3% | 7.86% | 9.44% | 12.2% | 11.2% | 10.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | 20.00 | - | 20.30 |
Cash Flow per Share 2 | -11.70 | -2.230 | -5.540 | - | 2.570 | 2.010 | 1.760 |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 3/4/20 | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.17% | 643M | |
+3.74% | 12.61B | |
+5.50% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- CCAP Stock
- Financials Crescent Capital BDC, Inc.